{"podcast":{"title":"US News Today | 2 Min News | The Daily News Now!","slug":"us-news-today-2-min-news-the-daily-news-now-7023297","podcast_index_feed_id":7023297,"rss_url":"https://feeds.fastcast.ai/who-the-is-chuck-taylor.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/who-the-is-chuck-taylor.jpg","author":"The Daily News Now!","episode_count":1314,"summary":"Hosted by Corey with the Story, US News Today delivers daily coverage of the biggest stories shaping the United States with fast, focused updates on national news, politics, business, economy, public safety, and cultural moments. From breaking headlines to ongoing national developments, the show keeps you informed on what matters most across the country. Each short episode highlights what matters most—including key updates, national trends, and major storylines—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, US News Today is built for listeners who want reliable national news coverage in a quick, easy-to-digest format. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-20T06:20:39.345774+00:00","page_url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297"},"episode":{"title":"New Drug Offers Hope for Head and Neck Cancer","slug":"new-drug-offers-hope-for-head-and-neck-cancer","published_at":"2026-05-30T21:38:58+00:00","page_url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297/new-drug-offers-hope-for-head-and-neck-cancer","show_page_url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297","url":"https://api.fastcast.ai/audio/bfc89755-7c50-4d46-a671-8b1afb1e26d4.mp3","audio_url":"https://api.fastcast.ai/audio/bfc89755-7c50-4d46-a671-8b1afb1e26d4.mp3","summary":"A groundbreaking new drug, amivantamab, is rewriting the playbook for advanced head and neck cancer—offering hope where none existed before. In trial OrigAMI-4, over 100 patients who’d failed standard treatments saw tumors shrink or vanish, with 15 achieving complete remission. This triple-action drug targets cancer’s fuel, dodges its defenses, and rallies the immune system—all via a simple injection. Real-life impact? One patient, Carl Walsh, went from struggling with tongue cancer to savoring steak again. For HPV-negative cancers, notoriously tough to treat, the median survival jumped to 12.5 months. Experts call it a major leap forward—a beacon of hope for patients with few options left. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/78d834c063847da9","meta_description":"A groundbreaking new drug, amivantamab, is rewriting the playbook for advanced head and neck cancer—offering hope where none existed before. In trial Orig…","key_points":[],"chapters":[],"topics":[],"duration_seconds":107,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/us-news-today-2-min-news-the-daily-news-now-7023297/episodes/new-drug-offers-hope-for-head-and-neck-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297/new-drug-offers-hope-for-head-and-neck-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}